Covid-19 origin mystery: ‘No direct evidence that it started in…’, says US intelligence report

US intelligence agencies have found no direct evidence to suggest the Covid-19 pandemic originated from an incident at China's Wuhan Institute of Virology. However, the agencies have not been able to rule out the possibility that the virus came from a laboratory.

Edited By Alka Jain
Published24 Jun 2023, 06:19 AM IST
No direct evidence COVID-19 started in Wuhan lab, says US intelligence report.
No direct evidence COVID-19 started in Wuhan lab, says US intelligence report.

“There is no direct evidence found that the Covid-19 pandemic stemmed from an incident at China’s Wuhan Institute of Virology,” a four-page report by US intelligence agencies said on Friday. 

It said the intelligence agencies could not rule out the possibility that the virus came from a laboratory. However, the agencies have not been to discover the Covid-19 pandemic origin, according to a report published by Reuters. 

"The Central Intelligence Agency and another agency remain unable to determine the precise origin of the Covid-19 pandemic, as both (natural and lab) hypotheses rely on significant assumptions or face challenges with conflicting reporting," the report said.

The agencies said that while "extensive work" had been conducted on coronaviruses at the Wuhan Institute (WIV), they had not found evidence of a specific incident that could have caused the outbreak.

"We continue to have no indication that the WIV's pre-pandemic research holdings included SARSCoV-2 or a close progenitor, nor any direct evidence that a specific research-related incident occurred involving WIV personnel before the pandemic that could have caused the COVID pandemic," the report added.

The SARS-CoV-2 virus was first identified in the Chinese city of Wuhan in December 2019 before fanning out around the world and killing nearly 7 million people.

Earlier in April, another report suggested that illegally traded wild animals in the Chinese city had triggered the coronavirus pandemic. But researchers have published the first-ever peer-reviewed analysis of biological evidence taken from the Wuhan wet market.

“The analysis confirms that swabs from the Huanan Seafood Wholesale Market — which closed in January 2020 and has long been linked to the start of the pandemic — contained genetic material from wild animals and tested positive for SARS-CoV-2," the paper said.

Meanwhile, the World Health Organization reiterated calls for China to share information, insisting that all hypotheses would continue to remain on the table until this happened.

Data from the early days of the COVID pandemic was briefly uploaded by Chinese scientists to an international database last month. It included genetic sequences found in more than 1,000 environmental and animal samples taken in January 2020 at the Huanan seafood market in Wuhan.

 

(With Reuters inputs)

Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:24 Jun 2023, 06:19 AM IST
Business NewsNewsWorldCovid-19 origin mystery: ‘No direct evidence that it started in…’, says US intelligence report

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Vedanta share price

    472.05
    03:59 PM | 17 OCT 2024
    -14.75 (-3.03%)

    Tata Steel share price

    152.35
    03:58 PM | 17 OCT 2024
    -2.9 (-1.87%)

    Bharat Petroleum Corporation share price

    342.50
    03:55 PM | 17 OCT 2024
    -8.35 (-2.38%)

    Tata Power share price

    450.05
    03:41 PM | 17 OCT 2024
    -10.3 (-2.24%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Coforge share price

    7,120.75
    10:51 AM | 7 OCT 2024
    -2.4 (-0.03%)

    Vijaya Diagnostic Centre share price

    984.80
    10:51 AM | 7 OCT 2024
    -4.15 (-0.42%)

    Dr. Lal Pathlabs share price

    3,408.00
    10:50 AM | 7 OCT 2024
    -86.25 (-2.47%)
    More from 52 Week High

    Bombay Burmah Trading Corporation share price

    2,519.95
    10:51 AM | 7 OCT 2024
    -245.3 (-8.87%)

    Jubilant Ingrevia share price

    728.55
    10:51 AM | 7 OCT 2024
    -65.7 (-8.27%)

    Triveni Engineering & Indus share price

    426.65
    10:51 AM | 7 OCT 2024
    -35.75 (-7.73%)

    Vodafone Idea share price

    9.08
    10:51 AM | 7 OCT 2024
    -0.72 (-7.35%)
    More from Top Losers

    Astrazeneca Pharma India share price

    7,832.35
    10:51 AM | 7 OCT 2024
    399.85 (5.38%)

    Finolex Industries share price

    280.85
    10:51 AM | 7 OCT 2024
    9.2 (3.39%)

    Macrotech Developers share price

    1,206.20
    10:51 AM | 7 OCT 2024
    34.35 (2.93%)

    JK Lakshmi Cement share price

    797.60
    10:51 AM | 7 OCT 2024
    17.2 (2.2%)
    More from Top Gainers

      Recommended For You

        More Recommendations

        Gold Prices

        • 24K
        • 22K
        Bangalore
        77,915.00510.00
        Chennai
        77,921.00510.00
        Delhi
        78,073.00510.00
        Kolkata
        77,925.00510.00

        Fuel Price

        • Petrol
        • Diesel
        Bangalore
        102.86/L0.00
        Chennai
        100.85/L0.10
        Kolkata
        104.95/L0.00
        New Delhi
        94.72/L0.00

        Popular in News

          HomeMarketsPremiumInstant LoanMint Shorts